comparemela.com
  1. Home
  2. Live Updates
  3. Vivavision Biotech Ltd - Breaking News

Vivavision Biotech Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

VVN539 met primary study endpoints in US phase IIa clinical study for the treatment of glaucoma

/PRNewswire/ This was a Phase 2, double-masked, randomized, vehicle-controlled, dose-response study to assess the safety and ocular hypotensive efficacy of.

Vivavision biotech ltdOcular hypertension

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.